Extract

This pilot, phase II trial studies how well everolimus and letrozole work in treating patients with hormone receptor positive ovarian, fallopian tube, or primary peritoneal cavity cancer that has come back. Everolimus and letrozole may stop the growth of tumor cells by blocking some the enzymes needed for cell growth.

Inclusion criteria

• Ovarian Endometrioid Adenocarcinoma,Ovarian Seromucinous Carcinoma,Ovarian Serous Cystadenocarcinoma,Ovarian Serous Surface Papillary Adenocarcinoma,Recurrent Fallopian Tube Carcinoma,Recurrent Ovarian Carcinoma,Recurrent Ovarian Germ Cell Tumor,Recurrent Primary Peritoneal Carcinoma,Undifferentiated Ovarian Carcinoma

Links

• nct
• ictrp